P Keerthi Reddy, 32, receives a doctor’s consultation before being administered with a dose of Eli Lilly’s Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and weight loss, at a health clinic in Hyderabad, India, April 14, 2025. REUTERS/Almaas Masood